Teva Valsartan/hctz Product Recall (2018-08-17)

Teva Valsartan/HCTZ Recall Teva is recalling valsartan/hydrochlorothiazide (HCTZ) medications across Canada due to a product safety issue. Valsartan/HCTZ is a combination blood pressure medication. The recall affects all patients who have been dispensed this medication in Canada.

Reason

Product safety

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2018-08-17

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/c154e9b6-51af-4582-9842-a586bb22cfea